| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.0038 | 0.9 |